Professor Geoffrey P Garnett

Publications


Journals

  • Tanser F; Bärnighausen T; Hund L; Garnett GP; McGrath N; Newell ML. (16 Jul 2011). Effect of concurrent sexual partnerships on rate of new HIV infections in a high-prevalence, rural South African population: a cohort study. Lancet. 378:247-255. DOI.
  • Schwartländer B; Stover J; Hallett T; Atun R; Avila C; Gouws E; Bartos M; Ghys PD; et alOpuni M; Barr D; Alsallaq R; Bollinger L; de Freitas M; Garnett G; Holmes C; Legins K; Pillay Y; Stanciole AE; McClure C; Hirnschall G; Laga M; Padian N; Investment Framework Study Group. (11 Jun 2011). Towards an improved investment approach for an effective response to HIV/AIDS. Lancet. 377:2031-2041. DOI.
  • Hallett TB; Gregson S; Dube S; Mapfeka ES; Mugurungi O; Garnett GP. (Dec 2011). Estimating the resources required in the roll-out of universal access to antiretroviral treatment in Zimbabwe. Sex Transm Infect. 87:621-628. DOI.
  • Marsh KA; Nyamukapa CA; Donnelly CA; Garcia-Calleja JM; Mushati P; Garnett GP; Mpandaguta E; Grassly NC; et alGregson S. (2011). Monitoring trends in HIV prevalence among young people, aged 15 to 24 years, in Manicaland, Zimbabwe. J Int AIDS Soc. 14:27. DOI.
  • Lodwick R; Alioum A; Archibald C; Birrell P; Commenges D; Costagliola D; De Angelis D; Donoghoe M; et alGarnett G; Ghys P; Law M; Lundgren J; Ndawinz J; Presanis A; Sabin C; Salminen M; Sommen C; Stanecki K; Stover J; Supervie V; Sweeting M; van de Laar M; van Sighem A; Wand H; Wilson D; Yan P; Phillips A; Working Grp Estimation HIV Prevale. (15 May 2011). HIV in hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV Working Group on Estimation of HIV Prevalence in Europe. AIDS. 25:1017-1023. DOI.
  • Fox J; White PJ; Weber J; Garnett GP; Ward H; Fidler S. (15 May 2011). Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm. AIDS. 25:1065-1082. DOI.
  • Garnett GP; Cousens S; Hallett TB; Steketee R; Walker N. (6 Aug 2011). Mathematical models in the evaluation of health programmes. Lancet. 378:515-525. DOI.
  • Wilson DP; Garnett GP. (Mar 2011). Introduction to recent developments in HIV epidemic modeling. Curr Opin HIV AIDS. 6:91-93. DOI.
  • Baussano I; Garnett G; Segnan N; Vineis P; Ronco G. (Sep 2010). CERVICAL CANCER PREVENTION: INSIGHT FROM DYNAMIC MODELING. EPIDEMIOL PREV. 34:101-102.
  • Gerver SM; Easterbrook PJ; Anderson M; Solarin I; Elam G; Fenton KA; Garnett G; Mercer CH. (Feb 2011). Sexual risk behaviours and sexual health outcomes among heterosexual black Caribbeans: comparing sexually transmitted infection clinic attendees and national probability survey respondents. Int J STD AIDS. 22:85-90. DOI.
  • Baussano I; Ronco G; Segnan N; French K; Vineis P; Garnett GP. (Mar 2010). HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions. Epidemics. 2:21-28. DOI.
  • Hallett TB; Gregson S; Mugurungi O; Gonese E; Garnett GP. E (ed). (2009). Assessing evidence for behaviour change affecting the course of HIV epidemics: A new mathematical modelling approach and application to data from Zimbabwe. Epidemics. 1:108-117. DOI.
  • Hallett TB; Dube S; Cremin I; Lopman B; Mahomva A; Ncube G; Mugurungi O; Gregson S; et alGarnett GP. (2009). The role of testing and counselling for HIV prevention and care in the era of scaling-up antiretroviral therapy. Epidemics. 1:77-82. DOI.
  • Pareek M; Abubakar I; White PJ; Garnett GP; Lalvani A. (Nov 2011). U.K. immigrant screening is inversely related to regional tuberculosis burden. Thorax. 66:1010. DOI.
  • Bórquez A; Hallett TB; Gomez GB; Garnett GP. (Apr 2011). Condom use by female sex workers and their clients in Mexico: who decides and does it matter?. Sex Transm Infect. 87:254-256. DOI Open Access copy.
  • Gregson S; Nyamukapa C; Schumacher C; Mugurungi O; Benedikt C; Mushati P; Campbell C; Garnett GP. (Jun 2011). Did national HIV prevention programs contribute to HIV decline in Eastern Zimbabwe? Evidence from a prospective community survey. Sex Transm Dis. 38:475-482. DOI.
  • Phillips AN; Pillay D; Garnett G; Bennett D; Vitoria M; Cambiano V; Lundgren J. (27 Mar 2011). Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. AIDS. 25:843-850. DOI.
  • Lacey CJ; Garnett GP. (Jan 2011). Promising control of genital warts: but is elimination possible?. Lancet Infect Dis. 11:4-6. DOI.
  • Baussano I; Garnett G; Segnan N; Ronco G; Vineis P. (1 Feb 2011). Modelling patterns of clearance of HPV-16 infection and vaccination efficacy. Vaccine. 29:1270-1277. DOI.
  • Ghys PD; Garnett GP. (Dec 2010). The 2009 HIV and AIDS estimates and projections: methods, tools and analyses. Sex Transm Infect. 86 Suppl 2:ii1-ii2. DOI.
  • Pareek M; Abubakar I; White PJ; Garnett GP; Lalvani A. (May 2011). Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice. Eur Respir J. 37:1175-1182. DOI.
  • Gregson S; Garnett GP. (13 Nov 2010). Antiretroviral treatment is a behavioural intervention: but why?. AIDS. 24:2739-2740. DOI.
  • Hallett TB; Gregson S; Kurwa F; Garnett GP; Dube S; Chawira G; Mason PR; Nyamukapa CA. (1 Oct 2010). Measuring and correcting biased child mortality statistics in countries with generalized epidemics of HIV infection. Bull World Health Organ. 88:761-768. DOI.
  • Eaton JW; Hallett TB; Garnett GP. (May 2011). Concurrent sexual partnerships and primary HIV infection: a critical interaction. AIDS Behav. 15:687-692. DOI.
  • Larson HJ; Brocard P; Garnett G. (21 Aug 2010). The India HPV-vaccine suspension. The Lancet. 376:572-573.
  • Gomez GB; Campos PE; Buendia C; Carcamo CP; Garcia PJ; Segura P; Whittington WL; Hughes JP; et alWard H; Garnett GP; Holmes KK. (Aug 2010). Studying complex interactions among determinants of healthcare-seeking behaviours: self-medication for sexually transmitted infection symptoms in female sex workers. Sex Transm Infect. 86:285-291. DOI.
  • Hallett TB; Smit C; Garnett GP; de Wolf F. (Feb 2011). Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Sex Transm Infect. 87:17-21. DOI.
  • Dodd PJ; White PJ; Garnett GP. (Oct 2010). Notions of synergy for combinations of interventions against infectious diseases in heterogeneously mixing populations. Math Biosci. 227:94-104. DOI.
  • Phillips AE; Gomez GB; Boily MC; Garnett GP. (Dec 2010). A systematic review and meta-analysis of quantitative interviewing tools to investigate self-reported HIV and STI associated behaviours in low- and middle-income countries. Int J Epidemiol. 39:1541-1555. DOI.
  • Eaton JW; Garnett GP; Ghys PD; Case KK; Mahy M. (May 2010). Measuring concurrent partnerships reply. LANCET. 375:1870-1870.
  • Phillips AE; Lowndes CM; Boily MC; Garnett GP; Gurav K; Ramesh BM; Anthony J; Moses S; et alAlary M. (Jun 2010). Men who have sex with men and women in Bangalore, South India, and potential impact on the HIV epidemic. Sex Transm Infect. 86:187-192. DOI.
  • Robertson L; Gregson S; Garnett GP. (Aug 2010). Sexual risk among orphaned adolescents: is country-level HIV prevalence an important factor?. AIDS Care. 22:927-938. DOI.
  • White PJ; Garnett GP. (2010). Mathematical Modelling of the Epidemiology of Tuberculosis. ADV EXP MED BIOL. 673:127-140.
  • Burington B; Hughes JP; Whittington WL; Stoner B; Garnett G; Aral SO; Holmes KK. (Apr 2010). Estimating duration in partnership studies: issues, methods and examples. Sex Transm Infect. 86:84-89. DOI.
  • Dodd PJ; Garnett GP; Hallett TB. (13 Mar 2010). Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS. 24:729-735. DOI.
  • Hallett TB; Singh K; Smith JA; White RG; Abu-Raddad LJ; Garnett GP. (21 May 2008). Understanding the Impact of Male Circumcision Interventions on the Spread of HIV in Southern Africa. PLOS ONE. 3. DOI.
  • Fung IC; Gambhir M; van Sighem A; de Wolf F; Garnett GP. (Mar 2010). Superinfection with a heterologous HIV strain per se does not lead to faster progression. Math Biosci. 224:1-9. DOI.
  • Choi YH; Jit M; Gay N; Cox A; Garnett GP; Edmunds WJ. (28 May 2010). Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom. Vaccine. 28:4091-4102. DOI.
  • Phillips AE; Boily MC; Lowndes CM; Garnett GP; Gurav K; Ramesh BM; Anthony J; Watts R; et alMoses S; Alary M. (2008). Sexual identity and its contribution to MSM risk behavior in Bangaluru (Bangalore), India: the results of a two-stage cluster sampling survey. J LGBT Health Res. 4:111-126.
  • Piot P; Garnett G. (3 Oct 2009). Health is global. Lancet. 374:1122-1123. DOI.
  • Cremin I; Nyamukapa C; Sherr L; Hallett TB; Chawira G; Cauchemez S; Lopman B; Garnett GP; et alGregson S. (Jun 2010). Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe. AIDS Behav. 14:708-715. DOI Open Access copy.
  • Zechmeister I; Blasio BF; Garnett G; Neilson AR; Siebert U. (13 Aug 2009). Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria. Vaccine. 27:5133-5141. DOI.
  • Hallett TB; Ghys P; Bärnighausen T; Yan P; Garnett GP. (2009). Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age. PLoS One. 4:e5720. DOI.
  • Cremin I; Mushati P; Hallett T; Mupambireyi Z; Nyamukapa C; Garnett GP; Gregson S. (Apr 2009). Measuring trends in age at first sex and age at marriage in Manicaland, Zimbabwe. Sex Transm Infect. 85 Suppl 1:i34-i40. DOI.
  • Bernabe-Ortiz A; White PJ; Carcamo CP; Hughes JP; Gonzales MA; Garcia PJ; Garnett GP; Holmes KK. (3 Feb 2009). Clandestine induced abortion: prevalence, incidence and risk factors among women in a Latin American country. CAN MED ASSOC J. 180:298-304. DOI.
  • Hallett T; Garnett G. (14 Jan 2009). Estimating Incidence of HIV Infection in Uganda. JAMA-J AM MED ASSOC. 301:159-159.
  • Gomez GB; Garnett GP; Ward H. (Feb 2009). Self-medication prevalence for sexually transmitted diseases: meta-analysis and meta-regression of population level determinants. Sex Transm Dis. 36:112-119. DOI.
  • Garnett GP; Baggaley RF. (3 Jan 2009). Treating our way out of the HIV pandemic: could we, would we, should we?. Lancet. 373:9-11. DOI Open Access copy.
  • Ryding J; French KM; Nauder R; Barnabas RV; Garnett GP; Dillner J. (26 Sep 2008). Seroepidemiology as basis for design of a human papillomavirus vaccination program. VACCINE. 26:5263-5268. DOI.
  • Looker KJ; Garnett GP; Schmid GP. (Oct 2008). An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 86:805-A.
  • Walker PT; Hallett TB; White PJ; Garnett GP. (Oct 2008). Interpreting declines in HIV prevalence: impact of spatial aggregation and migration on expected declines in prevalence. SEX TRANSM INFECT. 84:II42-II48. DOI.
  • Garnett GP; White PJ; Ward H. (Oct 2008). Fewer partners or more condoms? Modelling the effectiveness of STI prevention interventions. Sex Transm Infect. 84 Suppl 2:ii4-i11. DOI.
  • Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; et alSoorapanth S; Boily MC; Garnett GP; McElroy PD. (12 Sep 2008). Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS. 22:1829-1839. DOI.
  • Ghys PD; Walker N; McFarland W; Miller R; Garnett GP. (Aug 2008). Improved data, methods and tools for the 2007 HIV and AIDS estimates and projections. SEX TRANSM INFECT. 84:I1-I4. DOI.
  • Paz Soldan VA; Lee FH; Carcamo C; Holmes KK; Garnett GP; Garcia P. (Aug 2008). Who is getting Pap smears in urban Peru?. Int J Epidemiol. 37:862-869. DOI.
  • Garnett GP; Gazzard B. (26 Jul 2008). Risk of HIV transmission in discordant couples. Lancet. 372:270-271. DOI.
  • Robertson L; Gregson S; Madanhire C; Walker N; Mushati P; Garnett G; Nyamukapa C. (Aug 2008). Discrepancies between UN models and DHS survey estimates of maternal orphan prevalence: insights from analyses of survey data from Zimbabwe. Sex Transm Infect. 84 Suppl 1:i57-i62. DOI.
  • Garnett GP. (Jun 2008). How much infertility does chlamydia cause?. Sex Transm Infect. 84:157-158. DOI.
  • Hallett TB; Gregson S; Dube S; Garnett GP. (Mar 2008). The impact of monitoring HIV patients prior to treatment in resource-poor settings: Insights from mathematical modelling. PLOS MED. 5:403-412. DOI.
  • Smit C; Hallett TB; Lange J; Garnett G; de Wolf F. (2008). Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. PLoS One. 3:e1949. DOI.
  • Bernabe-Ortiz A; Curioso WH; Gonzales MA; Evangelista W; Castagnetto JM; Carcamo CP; Hughes JP; Garcia PJ; et alGarnett GP; Holmes KK. (2008). Handheld computers for self-administered sensitive data collection: a comparative study in Peru. BMC Med Inform Decis Mak. 8:11. DOI.
  • Lopman B; Nyamukapa C; Mushati P; Mupambireyi Z; Mason P; Garnett GP; Gregson S. (Feb 2008). HIV incidence in 3 years of follow-up of a Zimbabwe cohort - 1998-2000 to 2001-03: contributions of proximate and underlying determinants to transmission. INT J EPIDEMIOL. 37:88-105. DOI.
  • Hallett TB; Garnett GP; Mupamberiyi Z; Gregson S. (Feb 2008). Measuring effectiveness in community randomized trials of HIV prevention. Int J Epidemiol. 37:77-87. DOI.
  • Garnett GP. (Jan 2008). Inferring mechanisms for sexual partnership formation from the distribution of sexual partner numbers. SEX TRANSM DIS. 35:41-42. DOI.
  • Garnett GP. (Oct 2007). Theory is critical in understanding the risks of acquiring HIV. SEX TRANSM DIS. 34:737-738. DOI.
  • Gregson S; Nyamukapa C; Lopman B; Mushati P; Garnett GP; Chandiwana SK; Anderson RM. (11 Sep 2007). Critique of early models of the demographic impact of HIV/AIDS in sub-Saharan Africa based on contemporary empirical data from Zimbabwe. Proc Natl Acad Sci U S A. 104:14586-14591. DOI.
  • Cutts FT; Franceschi S; Goldie S; Castellsague X; de Sanjose S; Garnett G; Edmunds WJ; Claeys P; et alGoldenthal KL; Harper DM; Markowitz L. (Sep 2007). Human papillomavirus and HPV vaccines: a review. B WORLD HEALTH ORGAN. 85:719-726. DOI.
  • Hallett TB; White PJ; Garnett GP. (Aug 2007). Appropriate evaluation of HIV prevention interventions: from experiment to full-scale implementation. Sex Transm Infect. 83 Suppl 1:i55-i60. DOI.
  • Hallett TB; Gregson S; Lewis JJ; Lopman BA; Garnett GP. (Aug 2007). Behaviour change in generalised HIV epidemics: impact of reducing cross-generational sex and delaying age at sexual debut. Sex Transm Infect. 83 Suppl 1:i50-i54. DOI.
  • Lewis JJ; Donnelly CA; Mare P; Mupambireyi Z; Garnett GP; Gregson S. (Aug 2007). Evaluating the proximate determinants framework for HIV infection in rural Zimbabwe. Sex Transm Infect. 83 Suppl 1:i61-i69. DOI.
  • Mercer CH; Sutcliffe L; Johnson AM; White PJ; Brook G; Ross JD; Dhar J; Horner P; et alKeane F; Jungmann E; Sweeney J; Kinghorn G; Garnett GG; Stephenson JM; Cassell JA. (Aug 2007). How much do delayed healthcare seeking, delayed care provision, and diversion from primary care contribute to the transmission of STIs?. Sex Transm Infect. 83:400-405. DOI.
  • Hallett TB; Lewis JJC; Lopman BA; Nyamukapa CA; Mushati P; Wambe M; Garnett GP; Gregson S. (Mar 2007). Age at first sex and HIV infection in rural Zimbabwe. STUD FAMILY PLANN. 38:1-10.
  • Gregson S; Adamson S; Papaya S; Mundondo J; Nyamukapa CA; Mason PR; Garnett GP; Chandiwana SK; et alFoster G; Anderson RM. (Mar 2007). Impact and process evaluation of integrated community and clinic-based HIV-1 control: A cluster-randomised trial in eastern Zimbabwe. PLOS MED. 4:545-555. DOI.
  • Williams JR; Jordan JC; Davis EA; Garnett GP. (Mar 2007). Suppressive valacyclovir therapy: impact on the population spread of HSV-2 infection. Sex Transm Dis. 34:123-131. DOI.
  • French KM; Barnabas RV; Lehtinen M; Kontula O; Pukkala E; Dillner J; Garnett GP. (12 Feb 2007). Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland. Br J Cancer. 96:514-518. DOI.
  • Coffee M; Lurie MN; Garnett GP. (30 Jan 2007). Modelling the impact of migration on the HIV epidemic in South Africa. AIDS. 21:343-350. DOI.
  • French KM; Riley S; Garnett GP. (Jan 2007). Network-Light Not Data-Free. Sex Transm Dis. 34:57-58. Publisher weblink DOI.
  • Campos PE; Buffardi AL; Chiappe M; Buendia C; Garcia PJ; Carcamo CP; Garnett G; White P; et alHolmes KK. (Dec 2006). Utility of the Determine Syphilis TP rapid test in commercial sex venues in Peru. SEX TRANSM INFECT. 82:V22-V25. DOI.
  • Lopman BA; French KM; Baggaley R; Gregson S; Garnett GP. (11 Sep 2006). HIV-contaminated syringes are not evidence of transmission. AIDS. 20:1905-1905.
  • White PJ; Ward H; Garnett GP. (11 Sep 2006). Is HIV out of control in the UK? An example of analysing patterns of HIV spreading using incidence-to-prevalence ratios. AIDS. 20:1898-1901. DOI.
  • Wright TC; Bosch FX; Franco EL; Cuzick J; Schiller JT; Garnett GP; Meheus A. (31 Aug 2006). HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. VACCINE. 24:251-261. DOI.
  • Goldie SJ; Goldhaber-Fiebert JD; Garnett GP. (31 Aug 2006). Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling. Vaccine. 24 Suppl 3:S3/155-S3/163. DOI.
  • Garnett GP; Kim JJ; French K; Goldie SJ. (31 Aug 2006). Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine. 24 Suppl 3:S3/178-S3/186. DOI.
  • Franco EL; Bosch FX; Cuzick J; Schiller JT; Garnett GP; Meheus A; Wright TC. (31 Aug 2006). Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer. Vaccine. 24 Suppl 3:S3/242-S3/249. DOI.
  • Lopman BA; Barnabas RV; Boerma JT; Chawira G; Gaitskell K; Harrop T; Mason P; Donnelly CA; et alGarnett GP; Nyamukapa C; Gregson S. (Aug 2006). Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy. PLoS Med. 3:e312. DOI.
  • Hallett TB; Garnett GP. (8 Jul 2006). Has global HIV incidence peaked?. LANCET. 368:116-117.
  • Ghys PD; Walker N; Garnett GP. (Jun 2006). Improving analysis of the size and dynamics of AIDS epidemics. SEX TRANSM INFECT. 82:1-2. DOI.
  • Ghys PD; Walker N; Garnett GP. (Jun 2006). Improving analysis of the size and dynamics of AIDS epidemics. Sex Transm Infect. 82 Suppl 3:iii1-iii2. DOI.
  • Brown T; Grossly NC; Garnett G; Stanecki K. (Jun 2006). Improving projections at the country level: the UNAIDS Estimation and Projection Package 2005. SEX TRANSM INFECT. 82:34-40. DOI.
  • Brown T; Grassly NC; Garnett G; Stanecki K. (1 Jun 2006). Improving projections at the country level: the UNAIDS Estimation and Projection Package 2005. SEX TRANSM INFECT. 82:III34-III40. DOI.
  • Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP. (May 2006). Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med. 3:e138. DOI.
  • Garnett GP; Garcia-Calleja JM; Rehle T; Gregson S. (Apr 2006). Behavioural data as an adjunct to HIV surveillance data. Sex Transm Infect. 82 Suppl 1:i57-i62. DOI.
  • Garnett GP; Gregson S; Stanecki KA. (Apr 2006). Criteria for detecting and understanding changes in the risk of HIV infection at a national level in generalised epidemics. Sex Transm Infect. 82 Suppl 1:i48-i51. DOI.
  • Hallett TB; Aberle-Grasse J; Boulos LM; Cayemittes MPA; Cheluget B; Chipeta J; Dorrington R; Dube S; et alEkra AK; Garcia-Calleja JM; Garnett GP; Greby S; Gregson S; Grove JT; Hader S; Hanson J; Hladik W; Ismail S; Kassim S; Kirungi W; Kouassi L; Mahomva A; Marum L; Maurice C; Nolan M; Rehle T; Stover J; Walker N. (1 Apr 2006). Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti. SEX TRANSM INFECT. 82:I1-I8. DOI.
  • Baggaley RF; Garnett GP; Ferguson NM. (Apr 2006). Modelling the impact of antiretroviral use in resource-poor settings. PLOS MED. 3:493-504. DOI.
  • Stover J; Bertozzi S; Gutierrez JP; Walker N; Stanecki KA; Greener R; Gouws E; Hankins C; et alGarnett GP; Salomon JA; Boerma JT; De Lay P; Ghys PD. (10 Mar 2006). The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. SCIENCE. 311:1474-1476. DOI.
  • Lopman BA; Barnabas R; Hallett TB; Nyamukapa C; Mundandi C; Mushati P; Garnett GP; Gregson S. (Mar 2006). Assessing adult mortality in HIV-1-afflicted Zimbabwe (1998-2003). B WORLD HEALTH ORGAN. 84:189-197.
  • French K; Riley S; Garnett G. (Mar 2006). Simulations of the HIV epidemic in sub-Saharan Africa: sexual transmission versus transmission through unsafe medical injections. Sex Transm Dis. 33:127-134. DOI.
  • Gregson S; Garnett GP; Nyamukapa CA; Hallett TB; Lewis JJ; Mason PR; Chandiwana SK; Anderson RM. (3 Feb 2006). HIV decline associated with behavior change in eastern Zimbabwe. Science. 311:664-666. DOI.
  • Boerma JT; Stanecki KA; Newell ML; Luo C; Beusenberg M; Garnett GP; Little K; Calleja JG; et alCrowley S; Kim JY; Zaniewski E; Walker N; Stover J; Ghys PD. (Feb 2006). Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. B WORLD HEALTH ORGAN. 84:145-150.
  • Bchir A; Bhutta Z; Binka F; Black R; Bradshaw D; Garnett G; Hayashi K; Jha P; et alPeto R; Sawyer C; Schwartlander B; Walker N; Wolfson M; Yach D; Zaba B. (21 Jan 2006). Better health statistics are possible. LANCET. 367:190-193.
  • Garnett GP. (2006). Intervention impacts dependence on socio-epiderniologic context and target groups. INT J STD AIDS. 17:6-7.
  • Desai K; Boily MC; Garnett GP; Mâsse BR; Moses S; Bailey RC. (2006). The role of sexually transmitted infections in male circumcision effectiveness against HIV--insights from clinical trial simulation. Emerg Themes Epidemiol. 3:19. DOI.
  • Gregson S; Nyamukapa CA; Garnett GP; Wambe M; Lewis JJ; Mason PR; Chandiwana SK; Anderson RM. (Oct 2005). HIV infection and reproductive health in teenage women orphaned and made vulnerable by AIDS in Zimbabwe. AIDS Care. 17:785-794. DOI.
  • Baggaley RF; Ferguson NM; Garnett GP. (10 Sep 2005). The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol. 2:9. DOI.
  • White PJ; Ward H; Cassell JA; Mercer CH; Garnett GP. (1 Sep 2005). Vicious and virtuous circles in the dynamics of infectious disease and the provision of health care: gonorrhea in Britain as an example. J Infect Dis. 192:824-836. DOI.
  • Lewis JJ; Garnett GP; Nyamukapa CA; Donnelly CA; Mason PR; Gregson S. (Aug 2005). Patterns of uptake of treatment for self reported sexually transmitted infection symptoms in rural Zimbabwe. Sex Transm Infect. 81:326-332. DOI.
  • Lewis JJ; Garnett GP; Mhlanga S; Nyamukapa CA; Donnelly CA; Gregson S. (Jun 2005). Beer halls as a focus for HIV prevention activities in rural Zimbabwe. Sex Transm Dis. 32:364-369.
  • Sexton J; Garnett G; Røttingen JA. (Jun 2005). Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis. 32:351-357.
  • Zuma K; Lurie MN; Williams BG; Mkaya-Mwamburi D; Garnett GP; Sturm AW. (Jun 2005). Risk factors of sexually transmitted infections among migrant and non-migrant sexual partnerships from rural South Africa. Epidemiol Infect. 133:421-428.
  • Lopman BA; Garnett GP; Gregson S; Mason PR. (May 2005). Authors' reply: Don't let the hypothesis slip. PLOS MED. 2:459-461. DOI.
  • Grassly NC; Garnett GP. (May 2005). The future of the HIV pandemic. Bull World Health Organ. 83:378-382.
  • Looker KJ; Garnett GP. (Apr 2005). A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect. 81:103-107. DOI.
  • Lopman BA; Garnett GP; Mason PR; Gregson S. (Feb 2005). Individual level injection history: a lack of association with HIV incidence in rural Zimbabwe. PLoS Med. 2:e37. DOI.
  • Coffee MP; Garnett GP; Mlilo M; Voeten HACM; Chandiwana S; Gregson S. (1 Feb 2005). Patterns of movement and risk of HIV infection in rural Zimbabwe. J INFECT DIS. 191:S159-S167.
  • Garnett GP. (1 Feb 2005). Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J INFECT DIS. 191:S97-S106.
  • Grassly NC; Fraser C; Garnett GP. (27 Jan 2005). Host immunity and synchronized epidemics of syphilis across the United States. Nature. 433:417-421. DOI.
  • Turner KM; Garnett GP; Ghani AC; Sterne JA; Low N. (Oct 2004). Investigating ethnic inequalities in the incidence of sexually transmitted infections: mathematical modelling study. Sex Transm Infect. 80:379-385. DOI.
  • Garnett GP; Grassly NC; Boerma JT; Ghys PD. (1 Aug 2004). HIV surveillance data analytical tools - Maximising the global use of HIV surveillance data through the development and sharing of analytical tools. SEX TRANSM INFECT. 80. DOI.
  • Ghys PD; Brown T; Grassly NC; Garnett G; Stanecki KA; Stover J; Walker N. (Aug 2004). The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics. Sex Transm Infect. 80 Suppl 1:i5-i9. DOI.
  • Grassly NC; Morgan M; Walker N; Garnett G; Stanecki KA; Stover J; Brown T; Ghys PD. (Aug 2004). Uncertainty in estimates of HIV/AIDS: the estimation and application of plausibility bounds. Sex Transm Infect. 80 Suppl 1:i31-i38. DOI.
  • Walker N; Grassly NC; Garnett GP; Stanecki KA; Ghys PD. (26 Jun 2004). Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic?. Lancet. 363:2180-2185. DOI.
  • Schneeberger A; Mercer CH; Gregson SA; Ferguson NM; Nyamukapa CA; Anderson RM; Johnson AM; Garnett GP. (Jun 2004). Scale-free networks and sexually transmitted diseases: a description of observed patterns of sexual contacts in Britain and Zimbabwe. Sex Transm Dis. 31:380-387.
  • Schmid GP; Buvé A; Mugyenyi P; Garnett GP; Hayes RJ; Williams BG; Calleja JG; De Cock KM; et alWhitworth JA; Kapiga SH; Ghys PD; Hankins C; Zaba B; Heimer R; Boerma JT. (7 Feb 2004). Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet. 363:482-488. DOI.
  • Garnett GP; Dubin G; Slaoui M; Darcis T. (Feb 2004). The potential epidemiological impact of a genital herpes vaccine for women. Sex Transm Infect. 80:24-29.
  • Garnett GP; Fraser C. (Nov 2003). Let it be sexual--selection, aggregation and distortion used to construct a case against sexual transmission. Int J STD AIDS. 14:782-784. DOI.
  • Lurie MN; Williams BG; Zuma K; Mkaya-Mwamburi D; Garnett GP; Sweat MD; Gittelsohn J; Karim SS. (17 Oct 2003). Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS. 17:2245-2252. DOI.
  • Pisani E; Garnett GP; Grassly NC; Brown T; Stover J; Hankins C; Walker N; Ghys PD. (21 Jun 2003). Back to basics in HIV prevention: focus on exposure. BMJ. 326:1384-1387. DOI.
  • Adams EJ; Garcia PJ; Garnett GP; Edmunds WJ; Holmes KK. (May 2003). The cost-effectiveness of syndromic management in pharmacies in Lima, Peru. Sex Transm Dis. 30:379-387.
  • Lurie MN; Williams BG; Zuma K; Mkaya-Mwamburi D; Garnett G; Sturm AW; Sweat MD; Gittelsohn J; et alAbdool Karim SS. (Feb 2003). The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis. 30:149-156.
  • Lowndes CM; Renton A; Alary M; Rhodes T; Garnett G; Stimson G. (2003). Conditions for widespread heterosexual spread of HIV in the Russian Federation: implications for research, monitoring and prevention. International Journal of Drug Policy. 14:45-62.
  • Grassly NC; Garnett GP. (2003). Explicit models make better policy. International Journal of Drug Policy. 14:339-341.
  • Grassly NC; Lowndes C; Rhodes T; Judd A; Renton A; Garnett GP. (2003). Modelling emerging HIVepidemics: the role of injecting drug use and sexual transmission in the Russian Federation, China and India. International Journal of Drug Policy. 30:379-387.
  • Røttingen JA; Garnett GP. (Dec 2002). The epidemiological and control implications of HIV transmission probabilities within partnerships. Sex Transm Dis. 29:818-827.
  • Barnabas RV; Carabin H; Garnett GP. (Dec 2002). The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis. Sex Transm Infect. 78:425-429.
  • Fraser C; Ferguson NM; De Wolf F; Ghani AC; Garnett GP; Anderson RM. (21 Nov 2002). Antigen-driven T-cell turnover. J Theor Biol. 219:177-192.
  • Hughes JP; Garnett GP; Koutsky L. (Nov 2002). The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology. 13:631-639. DOI.
  • Stover J; Walker N; Garnett GP; Salomon JA; Stanecki KA; Ghys PD; Grassly NC; Anderson RM; et alSchwartländer B. (6 Jul 2002). Can we reverse the HIV/AIDS pandemic with an expanded response?. Lancet. 360:73-77. DOI.
  • Garnett GP; Bartley L; Grassly NC; Anderson RM. (Jul 2002). Antiretroviral therapy to treat and prevent HIV/AIDS in resource-poor settings. Nat Med. 8:651-654. DOI.
  • Bartley LM; Donnelly CA; Garnett GP. (Jul 2002). The seasonal pattern of dengue in endemic areas: mathematical models of mechanisms. Trans R Soc Trop Med Hyg. 96:387-397.
  • Artzrouni M; Brown T; Feeney G; Garnett G; Ghys P; Grassly N; Schneider D; Stanecki K; et alStover J; Schwartlander B; Walker N; Way P; Yan P; Zaba B; Zlotnik H; Timaeus I; Walker N; UNAIDS Reference Grp Estimates Mod. (14 Jun 2002). Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: Recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. AIDS. 16:W1-W14.
  • Gregson S; Nyamukapa CA; Garnett GP; Mason PR; Zhuwau T; Caraël M; Chandiwana SK; Anderson RM. (1 Jun 2002). Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet. 359:1896-1903. DOI.
  • Bartley LM; Carabin H; Vinh Chau N; Ho V; Luxemburger C; Hien TT; Garnett GP; Farrar J. (Apr 2002). Assessment of the factors associated with flavivirus seroprevalence in a population in Southern Vietnam. Epidemiol Infect. 128:213-220.
  • Garnett GP. (Apr 2002). The geographical and temporal evolution of sexually transmitted disease epidemics. SEX TRANSM INFECT. 78:I14-I19.
  • Garnett GP. (Apr 2002). The geographical and temporal evolution of sexually transmitted disease epidemics. Sex Transm Infect. 78 Suppl 1:i14-i19.
  • Turner KM; Garnett GP. (Apr 2002). The impact of the phase of an epidemic of sexually transmitted infection on the evolution of the organism. Sex Transm Infect. 78 Suppl 1:i20-i30.
  • Garnett GP. (Feb 2002). An introduction to mathematical models in sexually transmitted disease epidemiology. Sex Transm Infect. 78:7-12.
  • Garnett GP; Artzrouni M; Brown T; Feeney G; Ghys PD; Grassly NC; Lazzari S; Schneider D; et alStanecki K; Stover J; Schwartlander B; Walker N; Way P; Yan P; Zaba B; Zlotnik H; Boerma T; Brahmbhatt H; Calleja J; Chin J; Coutinho R; Dabis F; De Cock K; Fitzgerald D; Gray R; Kitayaporn D. (2002). Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: recommendations for the UNAIDS reference group on estimates, modelling and projections. Aids. 9, 16.
  • Garnett GP. (Nov 2001). Confounding and cofactors: the limits of observational epidemiology. Sex Transm Dis. 28:622-623.
  • Røttingen JA; Cameron DW; Garnett GP. (Oct 2001). A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?. Sex Transm Dis. 28:579-597.
  • Garnett GP; Røttingen JA. (30 Mar 2001). Measuring the risk of HIV transmission. AIDS. 15:641-643.
  • Gregson S; Mason PR; Garnett GP; Zhuwau T; Nyamukapa CA; Anderson RM; Chandiwana SK. (Mar 2001). A rural HIV epidemic in Zimbabwe? Findings from a population-based survey. Int J STD AIDS. 12:189-196.
  • Garnett GP; Grassly NC; Gregson S. (2001). AIDS: The makings of a development disaster?. J Int Dev. 13:391-409.
  • Grassly NC; Garnett GP; Schwartländer B; Gregson S; Anderson RM. (2001). The effectiveness of HIV prevention and the epidemiological context. Bull World Health Organ. 79:1121-1132.
  • Ward H; Ison CA; Day SE; Martin I; Ghani AC; Garnett GP; Bell G; Kinghorn G; et alWeber JN. (25 Nov 2000). A prospective social and molecular investigation of gonococcal transmission. Lancet. 356:1812-1817. DOI.
  • Garnett GP; Bowden FJ. (Nov 2000). Epidemiology and control and curable sexually transmitted diseases: opportunities and problems. Sex Transm Dis. 27:588-599.
  • Anderson RM; Garnett GP. (Nov 2000). Mathematical models of the transmission and control of sexually transmitted diseases. Sex Transm Dis. 27:636-643.
  • Ferguson NM; Garnett GP. (Nov 2000). More realistic models of sexually transmitted disease transmission dynamics: sexual partnership networks, pair models, and moment closure. Sex Transm Dis. 27:600-609.
  • Ghani AC; Garnett GP. (Nov 2000). Risks of acquiring and transmitting sexually transmitted diseases in sexual partner networks. Sex Transm Dis. 27:579-587.
  • Garnett GP; Waddell HC. (Oct 2000). Public health paradoxes and the epidemiological impact of an HPV vaccine. J Clin Virol. 19:101-111.
  • Bowden FJ; Garnett GP. (Aug 2000). Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions. Sex Transm Infect. 76:248-256.
  • Schwartländer B; Garnett G; Walker N; Anderson R. (7 Jul 2000). AIDS in a new millennium. Science. 289:64-66.
  • Schwartlander B; Garnett G; Walker N; Anderson R. (7 Jul 2000). AIDS special report - AIDS in a new millennium. SCIENCE. 289:64-67.
  • Mertz KJ; Finelli L; Levine WC; Mognoni RC; Berman SM; Fishbein M; Garnett G; St Louis ME. (Apr 2000). Gonorrhea in male adolescents and young adults in Newark, New Jersey: implications of risk factors and patient preferences for prevention strategies. Sex Transm Dis. 27:201-207.
  • Garnett GP; Bartley LM; Cameron DW; Anderson RM. (Mar 2000). Both a 'magic bullet' and good aim are required to link public health interests and health care needs in HIV infection. Nat Med. 6:261-262. DOI.
  • Gregson S; Garnett GP. (2000). Contrasting gender differentials in HIV-1 prevalence and associated mortality increase in eastern and southern Africa: artefact of data or natural course of epidemics'. AIDS. 14:S85-S99.
  • Pequegnat W; Fishbein M; Celentano D; Ehrhardt A; Garnett G; Holtgrave D; Jaccard J; Schachter J; et alZenilman J. (Mar 2000). NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. Sex Transm Dis. 27:127-132.
  • Ferguson NM; deWolf F; Ghani AC; Fraser C; Donnelly CA; Reiss P; Lange JM; Danner SA; et alGarnett GP; Goudsmit J; Anderson RM. (21 Dec 1999). Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 96:15167-15172.
  • Coen PG; Heath PT; Garnett GP. (Dec 1999). The Hib immunization programme in the Oxford region: an analysis of the impact of vaccine administration on the incidence of disease. Epidemiol Infect. 123:389-402.
  • Bowden FJ; Garnett GP. (Dec 1999). Why is Trichomonas vaginalis ignored?. Sex Transm Infect. 75:372-374.
  • Garnett GP; Mertz KJ; Finelli L; Levine WC; St Louis ME. (29 Apr 1999). The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, New Jersey. Philos Trans R Soc Lond B Biol Sci. 354:787-797. DOI.
  • Garnett GP; Brunham RC. (Apr 1999). Magic bullets need accurate guns--syphilis eradication, elimination, and control. Microbes Infect. 1:395-404.
  • Kilian AH; Gregson S; Ndyanabangi B; Walusaga K; Kipp W; Sahlmüller G; Garnett GP; Asiimwe-Okiror G; et alKabagambe G; Weis P; von Sonnenburg F. (25 Feb 1999). Reductions in risk behaviour provide the most consistent explanation for declining HIV-1 prevalence in Uganda. AIDS. 13:391-398.
  • White PJ; Garnett GP. (Feb 1999). Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2. Sex Transm Infect. 75:49-54.
  • Gregson S; Zaba B; Garnett GP. (1999). Low fertility in women with HIV and the impact of the epidemic on orphanhood and early childhood mortality in sub-Saharan Africa. AIDS. 13 Suppl A:S249-S257.
  • Dye C; Garnett GP; Sleeman A; Williams BG. (12 Dec 1998). Prospects for worldwide tuberculosis control under the WHO DOTS strategy. LANCET. 352:1886-1891.
  • Dye C; Garnett GP; Sleeman K; Williams BG. (12 Dec 1998). Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet. 352:1886-1891.
  • Ghani AC; Donnelly CA; Garnett GP. (30 Sep 1998). Sampling biases and missing data in explorations of sexual partner networks for the spread of sexually transmitted diseases. Stat Med. 17:2079-2097.
  • Coen PG; Heath PT; Barbour ML; Garnett GP. (Jun 1998). Mathematical models of Haemophilus influenzae type b. Epidemiol Infect. 120:281-295.
  • Garnett GP. (Jun 1998). The basic reproductive rate of infection and the course of HIV epidemics. AIDS Patient Care STDS. 12:435-449.
  • Surasiengsunk S; Kiranandana S; Wongboonsin K; Garnett GP; Anderson RM; van Griensven GJ. (7 May 1998). Demographic impact of the HIV epidemic in Thailand. AIDS. 12:775-784.
  • Garnett GP; Johnson AM. (Apr 1997). Coining a new term in epidemiology: concurrency and HIV. AIDS. 11:681-683.
  • Garnett GP; Aral SO; Hoyle DV; Cates W; Anderson RM. (Apr 1997). The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sex Transm Dis. 24:185-200.
  • Anderson RM; Garnett GP. (1 Feb 1997). HIV vaccines - Reply. LANCET. 349:361-361.
  • Woolhouse ME; Dye C; Etard JF; Smith T; Charlwood JD; Garnett GP; Hagan P; Hii JL; et alNdhlovu PD; Quinnell RJ; Watts CH; Chandiwana SK; Anderson RM. (7 Jan 1997). Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A. 94:338-342.
  • Ghani AC; Swinton J; Garnett GP. (Jan 1997). The role of sexual partnership networks in the epidemiology of gonorrhea. Sex Transm Dis. 24:45-56.
  • Ghani AC; Ison CA; Ward H; Garnett GP; Bell G; Kinghorn GR; Weber J; Day S. (Nov 1996). Sexual partner networks in the transmission of sexually transmitted diseases. An analysis of gonorrhea cases in Sheffield, UK. Sex Transm Dis. 23:498-503.
  • Anderson RM; Garnett GP. (12 Oct 1996). Low-efficacy HIV vaccines: potential for community-based intervention programmes. Lancet. 348:1010-1013.
  • Garnett GP; Anderson RM. (Oct 1996). Sexually transmitted diseases and sexual behavior: insights from mathematical models. J Infect Dis. 174 Suppl 2:S150-S161.
  • Garnett GP; Ferguson NM. (Sep 1996). Predicting the effect of varicella vaccine on subsequent cases of zoster and varicella. Rev Med Virol. 6:151-161. DOI.
  • Ferguson NM; Anderson RM; Garnett GP. (9 Jul 1996). Mass vaccination to control chickenpox: the influence of zoster. Proc Natl Acad Sci U S A. 93:7231-7235.
  • Garnett GP; Anderson RM. (May 1996). Antiviral therapy and the transmission dynamics of HIV-1. J ANTIMICROB CHEMOTH. 37:135-150.
  • Garnett GP; Hughes JP; Anderson RM; Stoner BP; Aral SO; Whittington WL; Handsfield HH; Holmes KK. (May 1996). Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis. 23:248-257.
  • Garnett GP; Holmes EC. (Feb 1996). The ecology of emergent infectious disease - Infectious diseases pose an ever-emerging threat to humanity. BIOSCIENCE. 46:127-135.
  • Anderson RM; Swinton J; Garnett GP. (22 Aug 1995). Potential impact of low efficacy HIV-1 vaccines in populations with high rates of infection. Proc Biol Sci. 261:147-151. DOI.
  • Garnett GP; Anderson RM. (15 Aug 1995). Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. J Acquir Immune Defic Syndr Hum Retrovirol. 9:500-513.
  • Holmes EC; Nee S; Rambaut A; Garnett GP; Harvey PH. (29 Jul 1995). Revealing the history of infectious disease epidemics through phylogenetic trees. Philos Trans R Soc Lond B Biol Sci. 349:33-40. DOI.
  • GREGSON S; GARNETT GP; ANDERSON RM. (Nov 1994). ASSESSING THE POTENTIAL IMPACT OF THE HIV-1 EPIDEMIC AN ORPHANHOOD AND THE DEMOGRAPHIC-STRUCTURE OF POPULATIONS IN SUB-SAHARAN AFRICA. POP STUD-J DEMOG. 48:435-458.
  • GARNETT GP; SWINTON J; PARKER G. (Sep 1994). SEX ACTS AND SEX PARTNERS. J ACQ IMMUN DEF SYND. 7:989-990.
  • Garnett GP; Swinton J; Parker G. (Sep 1994). Sex acts and sex partners. J Acquir Immune Defic Syndr. 7:989-990.
  • Gregson S; Garnett GP; Anderson RM. (Aug 1994). Is HIV-1 likely to become a leading cause of adult mortality in sub-Saharan Africa?. J Acquir Immune Defic Syndr. 7:839-852.
  • HOLMES EC; GARNETT GP. (Jul 1994). GENES, TREES AND INFECTIONS - MOLECULAR EVIDENCE IN EPIDEMIOLOGY. TRENDS ECOL EVOL. 9:256-260.
  • GARNETT G; ANDERSON R. (10 Feb 1994). AIDS IN AFRICA - IS IT A MYTH. NATURE. 367:504-504.
  • Garnett G; Anderson R. (10 Feb 1994). AIDS in Africa: is it a myth?. Nature. 367:504. DOI.
  • Garnett GP; Anderson RM. (1994). Balancing sexual partnerships in an age and activity stratified model of HIV transmission in heterosexual populations. IMA J Math Appl Med Biol. 11:161-192.
  • Gregson S; Garnett GP; Shakespeare R; Foster G; Anderson RM. (1994). Determinants of the demographic impact of HIV-1 in sub-Saharan Africa: the effect of a shorter mean adult incubation period on trends in orphanhood. Health Transit Rev. 4 Suppl:65-92.
  • Garnett G; Anderson R. (23 Dec 1993). AIDS, HIV and the Sunday Times. Nature. 366:716. DOI.
  • GARNETT G; ANDERSON R. (23 Dec 1993). AIDS, HIV AND THE SUNDAY-TIMES. NATURE. 366:716-716.
  • Garnett GP; Anderson RM. (29 Oct 1993). Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes. Philos Trans R Soc Lond B Biol Sci. 342:137-159. DOI.
  • Garnett GP; Anderson RM. (Jul 1993). Contact tracing and the estimation of sexual mixing patterns: the epidemiology of gonococcal infections. Sex Transm Dis. 20:181-191.
  • BRUNHAM RC; CHEANG M; MCMASTER J; GARNETT G; ANDERSON R. (May 1993). CHLAMYDIA-TRACHOMATIS, INFERTILITY, AND POPULATION-GROWTH IN SUB-SAHARAN AFRICA. SEX TRANSM DIS. 20:168-173.
  • Garnett GP; Anderson RM. (Apr 1993). No reason for complacency about the potential demographic impact of AIDS in Africa. Trans R Soc Trop Med Hyg. 87 Suppl 1:S19-S22.
  • Garnett GP; Cox MJ; Bundy DA; Didier JM; St Catharine J. (Apr 1993). The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol Infect. 110:361-372.
  • Joyce CF; Garnett GP; Renton A; Whitaker L; Ison C. (Mar 1993). Persistence of multiple serovars of Neisseria gonorrhoeae. Sex Transm Dis. 20:105-109.
  • Garnett GP; Grenfell BT. (Jun 1992). The epidemiology of varicella-zoster virus infections: a mathematical model. Epidemiol Infect. 108:495-511.
  • Garnett GP; Grenfell BT. (Jun 1992). The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect. 108:513-528.
  • Swinton J; Garnett GP; Brunham RC; Anderson RM. (1992). Gonococcal infection, infertility, and population growth: I. Endemic states in behaviourally homogeneous growing populations. IMA J Math Appl Med Biol. 9:107-126.
  • Garnett GP; Swinton J; Brunham RC; Anderson RM. (1992). Gonococcal infection, infertility, and population growth: II. The influence of heterogeneity in sexual behaviour. IMA J Math Appl Med Biol. 9:127-144.
  • Brunham RC; Garnett GP; Swinton J; Anderson RM. (22 Nov 1991). Gonococcal infection and human fertility in sub-Saharan Africa. Proc Biol Sci. 246:173-177. DOI.
  • Anderson RM; May RM; Boily MC; Garnett GP; Rowley JT. (15 Aug 1991). The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS. Nature. 352:581-589. DOI.

Chapters in books

  • Garnett GP. The transmission dynamics of sexually transmitted infections. In Sexually Transmitted diseases. 4th:27-39. Holmes KK (ed); Sparling PF (ed); Stamm WE (ed); Piot P (ed); Wasserheit JN (ed); Corey L (ed); Cohen MS (ed); Watts DH (ed). McGraw-Hill, New York (2008).
  • Aral SO; Hughes J; Gorbach P; Stoner B; Manhart L; Garnett G; Foxman B; Golden M; et alHolmes KK. The Seattle 'sexual mixing', 'sexual networks' and 'sexual partnership types' studies. In Network Epidemiology: A handbook for survey design and data collection. 139-171. Morris M (ed). Oxford University Press, Oxford (2004).
  • Garnett GP; Ghani AC. The use of simulation models in exploring the influence of network structures on the epidemiology of sexually transmitted infections. In The network paradigm in research on drug abuse, HIV, and other blood-borne and sexually transmitted. 63-69. (2002).

Conferences

  • Lampinen T; Baggaley R; Garnett G; Chan K; Gataric N; Montaner J; Hogg R. A major determinant of recent increases in HIV incidence among men who have sex with men (MSM) in British Columbia (BC): Deferred initiation of antiretroviral therapy. 2nd North American Congress of Epidemiology. 163:S155-S155. (1 Jun 2006).
  • Desai K; Boily MC; Garnett G; Masse BR. The use of mathematical modeling to validate statistical power and estimation of protective efficacy of circumcision against HIV and STD in a current phase III study in Kisumu, Kenya. 24:84S-85S. (Jun 2003).
  • Desai K; Boily MC; Williams JR; Garnett G; Masse BR. The use of transmission dynamics models of infectious diseases to improve HIV prevention trials and public health decisions. 24:144S-144S. (Jun 2003).
  • Ghani AC; Garnett GP. Measuring sexual partner networks for transmission of sexually transmitted diseases. 161:227-238. (1998).
  • Garnett GP. The influence of behavioural heterogeneity on the population level effect of potential prophylactic type 1 human immunodeficiency virus vaccines. 161:209-225. (1998).
  • GARNETT GP; ANDERSON RM. NO REASON FOR COMPLACENCY ABOUT THE POTENTIAL DEMOGRAPHIC-IMPACT OF AIDS IN AFRICA. 87:19-22. (Apr 1993).
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook